3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Genitourinary
1
Breast
1
Conditions
Breast Neoplasms
5
Prostatic Neoplasms
2
Multiple Myeloma
2
Patient Compliance
1
Osteolysis
1
Bone Neoplasms
1
Interventions
pembrolizumab
2
Zoledronic Acid
2
Radiation
2
tocilizumab
1
saracatinib
1
poly ICLC
1
pegylated granulocyte colony-stimulating factor
1
montanide ISA 51
1
liposomal doxorubicin
1
fludarabine
1
flt3 ligand protein
1
cc-486
1
aldesleukin
1
Taxes
1
Surveys and Questionnaires
1
Standard of Care
1
Radiotherapy
1
Quality of Life
1
Psychology, Positive
1
Practice Guidelines as Topic
1
Patient Reported Outcome Measures
1
Palliative Care
1
Paclitaxel
1
Observation
1
Nivolumab
1
Molecular Diagnostic Techniques
1
Methods
1
Lomustine
1
Irinotecan
1
Ipilimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Bone Neoplasms
×
Clodronic Acid
×
Breast
×
Clear all
NCT00909142
2012-04-06
BICAM
Bayer
Completed
149 enrolled